Adjuvant Therapy | 2023 Best of Breast Conference Total Health | Oncology 46:31 1 year ago 6 139 Скачать Далее
monarchE: adjuvant abemaciclib + endocrine therapy in patients with HR+, HER2- high-risk eBC VJOncology 2:10 2 years ago 411 Скачать Далее
Adjuvant treatment for high risk HR+ breast cancer | ESMO 2023 Breast Cancer Highlights OncBrothers: Practice-Changing Cancer Discussions 0:29 8 months ago 152 Скачать Далее
monarchE: abemaciclib and adjuvant endocrine therapy for high-risk HR+ early breast cancer VJOncology 2:30 3 years ago 237 Скачать Далее
Adjuvant Therapy for Early-Stage HER2-Positive Breast Cancer OncLive 1:05:31 6 years ago 7 815 Скачать Далее
Factors Influencing Adjuvant Therapy Use for HER2+ Breast Cancer OncLive 5:16 6 years ago 257 Скачать Далее
Update from KAITLIN for high-risk HER2-positive early breast cancer ecancer 3:50 4 years ago 2 631 Скачать Далее
Extended Adjuvant Therapy for HER2-Positive Breast Cancer OncLive 8:21 7 years ago 1 237 Скачать Далее
ESMO 2020 Expert Video Report on CDK4 6i in the adjuvant treatment of breast cancer European Society for Medical Oncology (ESMO) 5:32 3 years ago 1 320 Скачать Далее
Optimizing Therapy in HER2+ Disease with Dr. Reshma Mahtani Total Health | Oncology 47:29 3 years ago 237 Скачать Далее
MonarchE: investigating adjuvant abemacicilib for high-risk HR+ breast cancer VJOncology 1:26 2 years ago 184 Скачать Далее
Adjuvant CDK4 and 6 Inhibition to Prevent Recurrences in High-Risk HR+/HER2- Early Breast Cancer PeerView Oncology 58:22 2 years ago 3 517 Скачать Далее
Adjuvant/Neoadjuvant Therapy for Breast Cancer: Updates and Molecular Predictors of Benefit HMP Education 38:22 7 years ago 4 358 Скачать Далее
Treatment for High- and Low-Risk HER2+ Breast Cancer Targeted Oncology 6:35 4 years ago 128 Скачать Далее
St. Gallen Consensus 2021: neoadjuvant and adjuvant therapy for HER2+ breast cancer VJOncology 3:11 3 years ago 372 Скачать Далее
HER2+ Early-Stage Breast Cancer: Peri-Operative Therapy OncLive 20:25 3 years ago 2 981 Скачать Далее
